A subset of patients was analyzed in-depth, and the antibody increase in the heterologous cohort was 1.6 times higher than that in the homologous cohort but did not reach statistical significance.
1
—
—
A subset of patients was analyzed in-depth, and the antibody increase in the heterologous cohort was 1.6 times higher than that in the homologous cohort but did not reach statistical significance.